GW Pharma to Raise $300M Via Public Offering | CashCropToday
0 Shares 99 Views

GW Pharma to Raise $300M Via Public Offering

October 2, 2018
99 Views

GW Pharmaceuticals plc (NASDAQ: GWPH) announced this morning that the company’s wholly owned subsidiary, Greenwich Biosciences, plans to raise $300 million dollars via the selling GW Pharma’s common shares on the NASDAQ Global Market.

The company is planning to offer the underwriters an additional 30-day option to purchase an additional $45 million of the company’s shares. Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, J.P. Morgan and Cowen and Company, LLC are acting as joint book-running managers for the offering.

GW Pharma recently had their cannabis derived CBD pharmaceutical drug, Epidiolex, approved by both the FDA and DEA to be sold and prescribed by licensed physicians. Epidiolex is an oral solution that is used for the reduction of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. The product is the first CBD based medicine approved by the United States government.

GW also commercialized the cannabinoid prescription drug, Sativex®, which is now approved for the treatment of multiple sclerosis in multiple countries outside the United States.  GW Pharma is currently conducted Phase 3 trails within the U.S. to get it approved as well. The company’s stock is currently trading at $13.04 per share.

You may be interested

CashCropToday | 411/420 | Cannapreneur Bo Money Discusses Events For Social Equity Plan (Part 3)
411420
8 views
411420
8 views

CashCropToday | 411/420 | Cannapreneur Bo Money Discusses Events For Social Equity Plan (Part 3)

Jaelynn Offerman - October 18, 2018

Host Joya Italiano continues her discussion with cannapreneur and social equity advocate, Bo Money. Bo reveals upcoming plans stored in place and discusses the reasoning behind the…

Public Companies iAnthus & MPX Bioceutical Announce Official Merger
Market Watch
7 views
Market Watch
7 views

Public Companies iAnthus & MPX Bioceutical Announce Official Merger

Editor - October 18, 2018

iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCQX: ITHUF), and MPX Bioceutical Corporation (CSE: MPX) (OTC: MPXEF) have announced this morning that the companies  signed an agreement to merge…

Aurora Cannabis to Debut on the New York Stock Exchange (NYSE) Next Week
Market Watch
30 views
Market Watch
30 views

Aurora Cannabis to Debut on the New York Stock Exchange (NYSE) Next Week

Editor - October 18, 2018

Aurora Cannabis Inc. (TSX: ACB) announced this morning that the company will be debuting its common shares on the New York Stock Exchange (“NYSE”), which will begin…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: